标题
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
作者
关键词
-
出版物
BIOORGANIC CHEMISTRY
Volume 133, Issue -, Pages 106425
出版商
Elsevier BV
发表日期
2023-02-16
DOI
10.1016/j.bioorg.2023.106425
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies
- (2022) Eman A. Abd El-Meguid et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The multi-molecular mechanisms of tumor-targeted drug resistance in precision medicine
- (2022) Xinming Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
- (2022) Abeer M. El-Naggar et al. BIOORGANIC CHEMISTRY
- Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy
- (2022) Lun Tan et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo
- (2022) Yin-Ru Li et al. BIOCHEMICAL PHARMACOLOGY
- Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities
- (2022) Jian Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy
- (2022) Yun Liu et al. Journal of Hematology & Oncology
- Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors
- (2022) Islam H. Ali et al. BIOORGANIC CHEMISTRY
- Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway
- (2022) Jian Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer
- (2022) Esraa A. Abdelsalam et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazoline and diarylamide fragments
- (2021) Ru Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis and biological evaluation of novel 2-(4-(1H-indazol-6-yl)-1H-pyrazol-1-yl)acetamide derivatives as potent VEGFR-2 inhibitors
- (2021) Xing-Rong Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, characterization, biological evaluation and molecular docking of a new quinazolinone-based derivative as a potent dual inhibitor for VEGFR-2 and EGFR tyrosine kinases
- (2021) Yassine Riadi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Design, synthesis and biological evaluation of dual HDAC and VEGFR inhibitors as multitargeted anticancer agents
- (2021) Xia Xue et al. INVESTIGATIONAL NEW DRUGS
- EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives
- (2021) Ahmed A.E. Mourad et al. LIFE SCIENCES
- Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
- (2021) Xiao-Jing Pang et al. MOLECULES
- Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy
- (2021) Xiu-Juan Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis
- (2021) Neha Upadhyay et al. BIOORGANIC CHEMISTRY
- Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-)
- (2021) Liping Hu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities
- (2021) Ya-Xin Sun et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and molecular docking of novel 2‐arylbenzothiazole multiangiokinase inhibitors targeting breast cancer
- (2020) Heba T. Abdel‐Mohsen et al. ARCHIV DER PHARMAZIE
- Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer
- (2020) Filippos Koinis et al. Cancers
- Antiangiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors
- (2020) Kang Cheng et al. CURRENT MEDICINAL CHEMISTRY
- Novel VEGFR‐2 inhibitors with an N ‐acylhydrazone scaffold
- (2020) Fernanda P. Pauli et al. ARCHIV DER PHARMAZIE
- Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect
- (2020) Sravani Sana et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives
- (2020) Omkulthom M. Alkamaly et al. ARCHIV DER PHARMAZIE
- Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective
- (2020) Yuan Gao et al. BIOCHEMICAL PHARMACOLOGY
- Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity
- (2020) Huda K. Mahmoud et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel piperazine–chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation
- (2020) Marwa F. Ahmed et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1-b]thiazole Derivatives as Potential Epidermal Growth Factor Receptor Inhibitors
- (2019) Xinshan Deng et al. MOLECULES
- Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile
- (2019) Aml E.-S. Mghwary et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio]acetamide derivatives as anticancer and radiosensitizing agents
- (2019) Aiten M. Soliman et al. BIOORGANIC CHEMISTRY
- Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
- (2019) Peter T Harrison et al. SEMINARS IN CANCER BIOLOGY
- Dual VEGFR-2/PIM-1 kinase inhibition towards surmounting the resistance to antiangiogenic agents via hybrid pyridine and thienopyridine-based scaffolds: Design, synthesis and biological evaluation
- (2019) Ola H. Rizk et al. BIOORGANIC CHEMISTRY
- Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors
- (2019) Heba T. Abdel-Mohsen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors
- (2019) Huiqiang Wei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Benzothiazole derivatives as anticancer agents
- (2019) Ali Irfan et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines
- (2018) Abbas Kabir et al. Anti-Cancer Agents in Medicinal Chemistry
- Design, synthesis and anticancer evaluation of 1 H -pyrazolo[3,4- d ]pyrimidine derivatives as potent EGFR WT and EGFR T790M inhibitors and apoptosis inducers
- (2018) Ahmed A. Gaber et al. BIOORGANIC CHEMISTRY
- Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells
- (2018) Srinivasa Rao Ramisetti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of novel N 1 -(2-aryl-1, 3-thiazolidin-4-one)- N 3 -aryl ureas showing potent multi-tyrosine kinase inhibitory activities
- (2018) Baohui Qi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-activity relationships of 2, 4-disubstituted pyrimidines as dual ERα/VEGFR-2 ligands with anti-breast cancer activity
- (2018) Guoshun Luo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, biological evaluation and molecular modeling of novel 1 H -pyrazolo[3,4-d]pyrimidine derivatives as BRAF V600E and VEGFR-2 dual inhibitors
- (2018) Yuanyuan Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
- (2018) Yoshiro Itatani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously
- (2018) Jie Zang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib
- (2018) Simon Vyse et al. Journal of Proteomics
- The PDGF/PDGFR pathway as a drug target
- (2018) Natalia Papadopoulos et al. MOLECULAR ASPECTS OF MEDICINE
- Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer
- (2018) Kristina Golfmann et al. ONCOGENE
- Formyl Peptide Receptor 1 Modulates Endothelial Cell Functions by NADPH Oxidase-Dependent VEGFR2 Transactivation
- (2018) Fabio Cattaneo et al. Oxidative Medicine and Cellular Longevity
- Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2
- (2018) Wei Shi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4
- (2017) Chuansheng Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2
- (2017) Hai-Qi Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities
- (2017) Jawaid Akhtar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo[g]quinazolin bearing benzenesulfonamide moiety
- (2017) Mostafa M. Ghorab et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Benzo[g]quinazolin-based scaffold derivatives as dual EGFR/HER2 inhibitors
- (2017) Mostafa M. Ghorab et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
- (2017) Liang Cheng et al. MODERN PATHOLOGY
- Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors
- (2017) Shaofeng Sun et al. MOLECULES
- Bisarylureas Based on 1H-Pyrazolo[3,4-d]pyrimidine Scaffold as Novel Pan-RAF Inhibitors with Potent Anti-Proliferative Activities: Structure-Based Design, Synthesis, Biological Evaluation and Molecular Modelling Studies
- (2017) Yu Fu et al. MOLECULES
- The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo
- (2017) Laurence Booth et al. Oncotarget
- A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status
- (2017) Benjamin Izar et al. Cancer Medicine
- Synthesis of 4-Anilinoquinazoline-Derivative Dual Kinase Inhibitors Targeting EGFR and VEGFR-2
- (2017) Keuk Chan Bang et al. BULLETIN OF THE KOREAN CHEMICAL SOCIETY
- Design, synthesis and biological evaluation of 4-aminopyrimidine-5-cabaldehyde oximes as dual inhibitors of c-Met and VEGFR-2
- (2016) Hao Qiang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects
- (2016) Dong Li et al. CANCER LETTERS
- Discovery of novel dual inhibitors of VEGFR and PI3K kinases containing 2-ureidothiazole scaffold
- (2016) Lin Li et al. CHINESE CHEMICAL LETTERS
- Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
- (2016) Leilei Shi et al. CURRENT MEDICINAL CHEMISTRY
- Identification of new potent phthalazine derivatives with VEGFR-2 and EGFR kinase inhibitory activity
- (2016) Kamilia M. Amin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs
- (2016) Jin Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors
- (2016) Hai-Qi Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of 6-aryl-indenoisoquinolone derivatives dual targeting ERα and VEGFR-2 as anti-breast cancer agents
- (2016) Zhichao Tang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC
- (2016) Fan-Wei Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
- (2016) MASARU KATOH INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Biological Evaluation of Some Imidazolidine-2,4-dione and 2-thioxoimidazolidin-4-one Derivatives as Anticoagulant Agents and Inhibition of MCF-7 Breast Cancer Cell Line
- (2016) Ashraf A. Mostafa et al. International Journal of Pharmacology
- Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia
- (2016) Huiqiang Wei et al. MOLECULES
- Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase
- (2015) Fan-Wei Peng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones
- (2015) Wagdy M. Eldehna et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues:in silicostudies
- (2015) Amer M. Alanazi et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis
- (2015) Guido Bold et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of thiourea and nicotinamide-containing sorafenib analogs as antitumor agents
- (2015) Xiangkai Kong et al. MedChemComm
- Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma
- (2015) Teresa E. Williams et al. ACS Medicinal Chemistry Letters
- Structure-Activity Relationship of Indole-Tethered Pyrimidine Derivatives that Concurrently Inhibit Epidermal Growth Factor Receptor and Other Angiokinases
- (2015) Jiho Song et al. PLoS One
- Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2
- (2014) Lei Shi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of 2,3-diaryl isoquinolinone derivatives as anti-breast cancer agents targeting ERα and VEGFR-2
- (2014) Zhichao Tang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors
- (2014) Lei Shi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Antitubulin Agents with Antiangiogenic Activity as Single Entities with Multitarget Chemotherapy Potential
- (2014) Aleem Gangjee et al. ACS Medicinal Chemistry Letters
- Design, synthesis, and biological evaluation of novel 3-pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives as potent receptor tyrosine kinase inhibitors
- (2013) Lei Ding et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effectin vivo
- (2013) S. Yasuda et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Structure–Activity Relationship Studies of Pyrazolo[3,4-d]pyrimidine Derivatives Leading to the Discovery of a Novel Multikinase Inhibitor That Potently Inhibits FLT3 and VEGFR2 and Evaluation of Its Activity against Acute Myeloid Leukemia in Vitro and in Vivo
- (2013) Ling-Ling Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion
- (2013) J. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Design, synthesis and biological activities of thiourea containing sorafenib analogs as antitumor agents
- (2012) Jianwen Yao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors
- (2012) Moon H. Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis and biological activities of sorafenib derivatives as antitumor agents
- (2012) Jianwen Yao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- VEGF Exerts an Angiogenesis-Independent Function in Cancer Cells to Promote Their Malignant Progression
- (2012) Ying Cao et al. CANCER RESEARCH
- Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
- (2012) C. Qian et al. CLINICAL CANCER RESEARCH
- 4-Aminopyrimidine-5-carbaldehyde oximes as potent VEGFR-2 inhibitors. Part II
- (2011) Shenlin Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors
- (2011) Hans-Peter Buchstaller et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer
- (2011) Matthew T. Burger et al. ACS Medicinal Chemistry Letters
- Synthesis and structure–activity relationship of 6-arylureido-3-pyrrol-2-ylmethylideneindolin-2-one derivatives as potent receptor tyrosine kinase inhibitors
- (2010) Rahul R. Khanwelkar et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: A potential clinical application of angiogenesis inhibitors
- (2010) Roshani R. Patel et al. EUROPEAN JOURNAL OF CANCER
- Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives
- (2010) Vijay Patil et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
- (2010) Kyungik Lee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- [4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors
- (2010) Antonio Garofalo et al. MedChemComm
- Synthesis, spectral analysis and in vitro microbiological evaluation of 3-(3-alkyl-2,6-diarylpiperin-4-ylidene)-2-thioxoimidazolidin-4-ones as a new class of antibacterial and antifungal agents
- (2009) J. Thanusu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
- (2009) F. Qian et al. CANCER RESEARCH
- Recent Advances in Selective Estrogen Receptor Modulators for Breast Cancer
- (2009) Tianlin Wang et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- TIE-2/VEGF-R2 SAR and in vitro activity of C3-acyl dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole analogs
- (2008) Ted L. Underiner et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell Lymphoma
- (2008) Carol Hogan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started